(Q37247606)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19433555%20AND%20SRC:MED&resulttype=core&format=json

27 January 2020

title

Safety and outcomes of open-label deferasirox iron chelation therapy for mucormycosis (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19433555%20AND%20SRC:MED&resulttype=core&format=json

27 January 2020

0 references

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19433555%20AND%20SRC:MED&resulttype=core&format=json

27 January 2020

6

Glenn E Mathisen

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19433555%20AND%20SRC:MED&resulttype=core&format=json

27 January 2020

7

Thomas J Walsh

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19433555%20AND%20SRC:MED&resulttype=core&format=json

27 January 2020

author name string

Brad Spellberg

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19433555%20AND%20SRC:MED&resulttype=core&format=json

27 January 2020

Mario Perez

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19433555%20AND%20SRC:MED&resulttype=core&format=json

27 January 2020

Anne Anglim

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19433555%20AND%20SRC:MED&resulttype=core&format=json

27 January 2020

Hector Bonilla

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19433555%20AND%20SRC:MED&resulttype=core&format=json

27 January 2020

Ashraf S Ibrahim

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19433555%20AND%20SRC:MED&resulttype=core&format=json

27 January 2020

language of work or name

English

0 references

publication date

11 May 2009

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19433555%20AND%20SRC:MED&resulttype=core&format=json

Antimicrobial Agents and Chemotherapy

27 January 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19433555%20AND%20SRC:MED&resulttype=core&format=json

27 January 2020

volume

53

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19433555%20AND%20SRC:MED&resulttype=core&format=json

27 January 2020

issue

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19433555%20AND%20SRC:MED&resulttype=core&format=json

27 January 2020

page(s)

3122-3125

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19433555%20AND%20SRC:MED&resulttype=core&format=json

Revised definitions of invasive fungal disease from the European Organization for Research and Treatment of Cancer/Invasive Fungal Infections Cooperative Group and the National Institute of Allergy and Infectious Diseases Mycoses Study Group (EORTC/

27 January 2020

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2704638

Clinical application of deferasirox: practical patient management

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2704638

The iron chelator deferasirox protects mice from mucormycosis through iron starvation

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2704638

A higher-level phylogenetic classification of the Fungi

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2704638

Epidemiology and outcome of zygomycosis: a review of 929 reported cases

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2704638

Novel perspectives on mucormycosis: pathophysiology, presentation, and management

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2704638

Iron-chelating therapy with the new oral agent ICL670 (Exjade).

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2704638

Mucormycosis during deferoxamine therapy is a siderophore-mediated infection. In vitro and in vivo animal studies

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2704638

Failure of deferasirox, an iron chelator agent, combined with antifungals in a case of severe zygomycosis.

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2704638

Deferasirox, an iron-chelating agent, as salvage therapy for rhinocerebral mucormycosis

3 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2704638

Deferiprone iron chelation as a novel therapy for experimental mucormycosis

3 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2704638

The effect of deferoxamine on different zygomycetes

3 September 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/19433555

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1128/AAC.00361-09

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19433555%20AND%20SRC:MED&resulttype=core&format=json

27 January 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19433555%20AND%20SRC:MED&resulttype=core&format=json

27 January 2020

PubMed publication ID

19433555

1 reference